Khyber Teaching Hospital
Peshawar, KPK, 25000, Pakistan
Location status: Recruiting
Location contact
Aimal Khan, MBBS
CONTACT
Aimal Khan, MBBS
PRINCIPAL_INVESTIGATOR
Arooj Khan, MBBS
CONTACT
NCT Number: NCT06742528
This study aims to compare the efficacy of two iron preparation for the management of children presented with iron deficiency anemia. Ferrous sulphate and lron polymaltose (ferric form) are most commonly used preparations. Both drugs are easily available in market and are often recommended by pediatriclans. The efficacy, bioavail.tbilily, side effects and cost of these preparations vary. This study is designed to find out a drug with better efficacy that can be used for treatment of iron deficiency anemia in local population.
Interested in participating?
Request Info6 month–5 year
All sexes
Interventional
Not applicable
Peshawar, KPK, 25000, Pakistan
Location status: Recruiting
Aimal Khan, MBBS
CONTACT
Aimal Khan, MBBS
PRINCIPAL_INVESTIGATOR
Arooj Khan, MBBS
CONTACT
Anemia remains a condition with high prevalence in populations worldwide. It is predominantly associated with nutritional status and socioeconomic conditions or hereditary diseases. The majority of anemia cases are linked to iron deficiency-named iron-deficiency anemia resulting from low intake of iron-rich foods in the diet, or from substantial blood loss.
This study aims to compare the efficacy of two iron preparation for the management of children presented with iron deficiency anemia. Ferrous sulphate and lron polymaltose (ferric form) are most commonly used preparations. Both drugs are easily available in market and are often recommended by pediatriclans. The efficacy, bioavail.tbilily, side effects and cost of these preparations vary. This study is designed to find out a drug with better efficacy that can be used for treatment of iron deficiency anemia in local population.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ferrous sulphate in a dose of 6mg/kg/day of elemental iron once daily for 8 weeks orally in syrup form.
Iron Polymaltose complex in a dose of 6mg/kg/day of elemental iron once daily orally for 8 weeks.
Time frame: 8 weeks
Increase in Hemoglobin level measured by a Complete Blood Count as compared to pre treatment Hemoglobin
Contact information is provided by the study sponsor or research team.
Arooj Khan
Other
Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients With Iron Deficiency Anemia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05340465
Anemia, Anemia, Hypochromic
Seattle, Washington, United States
View Trial DetailsNCT06238895
Anemia, Anemia, Hypochromic
Lucerne, Switzerland
View Trial DetailsNCT05919472
Anemia, Anemia, Hypochromic
Msambweni, Kenya
View Trial DetailsNCT07238972
Anemia, Anemia, Hypochromic
Seoul, South Korea
View Trial Details